Active Biotech
ACTI | ST
Overview
Corporate Details
- ISIN(s):
- SE0001137985 (+2 more)
- LEI:
- 549300OJ44CLMRU8YE43
- Country:
- Sweden
- Address:
- Scheelevägen 22, 223 63 Lund
- Sector:
- Health Care
- Industry:
- Biotechnology
Description
Active Biotech develops pharmaceutical products within medical areas where the immune system is of significant importance, including cancer and inflammatory diseases. The project portfolio comprises both small, orally active immunomodulatory molecules and antibody-based immunotherapy. Active Biotech has its base in Lund, Sweden and was formed in 1998 as a spin-off from Pharmacia & Upjohn. The share is listed and traded on Nasdaq Stockholm (Small Cap). The Company has core competence in cancer and inflammatory diseases and a competent team with extensive experience in drug development from early to late stage clinical development.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Filings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-06-17 15:15 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 10.7 KB | |
| 2025-05-28 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Annual General Meeting of Active Biotech AB
|
English | 76.1 KB | |
| 2025-05-28 18:30 |
Declaration of Voting Results & Voting Rights Announcements
Årsstämma i Active Biotech AB
|
Swedish | 74.1 KB | |
| 2025-05-08 08:30 |
Quarterly Report
|
Swedish | 406.4 KB | |
| 2025-05-08 08:30 |
Quarterly Report
|
English | 400.9 KB | |
| 2025-05-05 09:00 |
Earnings Release
Active Biotech rapporterar positiva top line-resultat från LION-studien om okul…
|
Swedish | 104.6 KB | |
| 2025-05-05 09:00 |
Earnings Release
Active Biotech reports positive top-line results from the LION study on ocular …
|
English | 104.9 KB | |
| 2025-04-28 11:00 |
Proxy Solicitation & Information Statements
NOTICE OF ANNUAL GENERAL MEETING
|
English | 98.7 KB | |
| 2025-04-28 11:00 |
General Meeting Notice
KALLELSE TILL ÅRSSTÄMMA
|
Swedish | 99.3 KB | |
| 2025-02-13 08:30 |
Regulatory News Service
|
Swedish | 511.4 KB | |
| 2025-02-13 08:30 |
Annual Report
|
English | 506.2 KB | |
| 2025-01-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Number of shares and votes in Active Biotech
|
English | 86.2 KB | |
| 2025-01-31 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Active Biotech
|
Swedish | 86.1 KB | |
| 2025-01-13 13:59 |
Declaration of Voting Results & Voting Rights Announcements
|
Swedish | 9.9 KB | |
| 2024-12-30 08:30 |
Declaration of Voting Results & Voting Rights Announcements
Antal aktier och röster i Active Biotech
|
Swedish | 82.7 KB |
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2025-01-10 | Peter Thelin | Other | Other | 164,638,960 | 8,231,948.00 SEK |
| 2024-11-15 | Hans Kolam | Other | Other | 19,800 | 990.00 SEK |
| 2022-09-05 | Aleksandar Danilovski | Other | Buy | 26,672 | 26,672.00 SEK |
| 2022-04-22 | Helen Tuvesson Andersson | Other | Buy | 2,665 | 3,102.86 SEK |
| 2022-04-21 | Helen Tuvesson Andersson | Other | Buy | 37,335 | 41,767.60 SEK |
| 2021-06-17 | Aleksandar Danilovski | Other | Buy | 40,000 | 60,000.00 SEK |
| 2021-06-01 | Michael Shalmi | Other | Buy | 175,000 | 259,437.50 SEK |
| 2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 10,411 | 16,657.60 SEK |
| 2021-04-27 | Helena Eriksson | Other | Buy | 10,000 | 14,460.00 SEK |
| 2021-04-27 | Helen Tuvesson Andersson | Other | Buy | 1,041 | 1,665.60 SEK |
Peer Companies
| Company | Country | Ticker | View | |
|---|---|---|---|---|
|
1NKEMIA | Spain | IKM | |
|
2cureX AB | Sweden | 2CUREX | |
|
4SC AG | Germany | VSC | |
|
Abera Bioscience AB | Sweden | ABERA | |
|
ABIONYX Pharma | France | ABNX | |
|
Abliva | Sweden | ABLI | |
|
AB Science | France | AB | |
|
Acticor Biotech | France | ALACT | |
|
AcuCort AB | Sweden | ACUC | |
|
Adocia | France | ADOC |